These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 33849433)

  • 41. Neoatherosclerosis causing occlusive in-stent restenosis: Impact of intracoronary imaging in the intensity of lipid-lowering therapy.
    Martí D; López E; Álvarez S; Palazuelos J; Rada I; Alfonso F
    Cardiovasc Revasc Med; 2016 Dec; 17(8):584-585. PubMed ID: 27743816
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Edge vascular response after percutaneous coronary intervention: an intracoronary ultrasound and optical coherence tomography appraisal: from radioactive platforms to first- and second-generation drug-eluting stents and bioresorbable scaffolds.
    Gogas BD; Garcia-Garcia HM; Onuma Y; Muramatsu T; Farooq V; Bourantas CV; Serruys PW
    JACC Cardiovasc Interv; 2013 Mar; 6(3):211-21. PubMed ID: 23517830
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Angiographic patterns of drug-eluting stent restenosis after treatment with drug-coated balloon versus balloon angioplasty: Late lumen loss subgroup analyses of the PEPCAD-DES study.
    Rittger H; Wöhrle J; Brachmann J; Hohenforst-Schmidt W; Schlundt C; Lonke S; von Cranach M; Markovic S; Achenbach S; Waliszewski M
    Catheter Cardiovasc Interv; 2016 Oct; 88(4):529-534. PubMed ID: 26893095
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The frequency and clinical characteristics of in-stent restenosis due to calcified nodule development after coronary stent implantation.
    Isodono K; Fujii K; Fujimoto T; Kasahara T; Ariyoshi M; Irie D; Tsubakimoto Y; Sakatani T; Matsuo A; Inoue K; Fujita H
    Int J Cardiovasc Imaging; 2021 Jan; 37(1):15-23. PubMed ID: 32734495
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Serial morphological and functional assessment of drug-eluting balloon for in-stent restenotic lesions: mechanisms of action evaluated with angiography, optical coherence tomography, and fractional flow reserve.
    Agostoni P; Belkacemi A; Voskuil M; Nathoe HM; Doevendans PA; Stella PR
    JACC Cardiovasc Interv; 2013 Jun; 6(6):569-76. PubMed ID: 23683736
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Impact of drug-eluting balloon (pre- or post-) dilation on neointima formation in de novo lesions treated by bare-metal stent: the IN-PACT CORO trial.
    Burzotta F; Brancati MF; Trani C; Pirozzolo G; De Maria G; Leone AM; Niccoli G; Porto I; Prati F; Crea F
    Heart Vessels; 2016 May; 31(5):677-86. PubMed ID: 25863804
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Analysis of the effect of paclitaxel-eluting stents and paclitaxel-eluting balloon in the treatment of in-stent restenosis.
    Cheng J; Gao C; Liu Y; Wang Z; Zheng X; Qi D
    Pak J Pharm Sci; 2017 Jul; 30(4(Suppl.)):1521-1524. PubMed ID: 29044008
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Potent Stent-Less Procedure Using Rotational Atherectomy and Drug-Coated Balloon to Right Coronary Ostial Lesion.
    Shiraishi J; Nishimura T; Kimura M; Koshi N; Matsubara Y; Ito D; Kishita E; Nakagawa Y; Hyogo M; Sawada T
    Cardiovasc Revasc Med; 2019 Sep; 20(9):822-826. PubMed ID: 30579774
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Role of Vascular Imaging in Guiding Routine Percutaneous Coronary Interventions: A Meta-Analysis of Bare Metal Stent and Drug-Eluting Stent Trials.
    Alsidawi S; Effat M; Rahman S; Abdallah M; Leesar M
    Cardiovasc Ther; 2015 Dec; 33(6):360-6. PubMed ID: 26363283
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The OCT-ORION Study: A Randomized Optical Coherence Tomography Study Comparing Resolute Integrity to Biomatrix Drug-Eluting Stent on the Degree of Early Stent Healing and Late Lumen Loss.
    Lee SWL; Tam FCC; Lam SCC; Kong SL; Shea CP; Chan KKW; Wong MKL; Chan MPH; Wong AYT; Yung ASY; Lam YM; Zhang LW; Wu KKY; Mintz GS; Maehara A
    Circ Cardiovasc Interv; 2018 Apr; 11(4):e006034. PubMed ID: 29654119
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A case of severely calcified neoatherosclerosis after paclitaxel eluting stent implantation.
    Yamamoto K; Sakakura K; Taniguchi Y; Wada H; Momomura SI; Fujita H
    Cardiovasc Revasc Med; 2017 Sep; 18(6S1):52-53. PubMed ID: 28342839
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Late stent thrombosis after the use of a bioresorbable vascular scaffold for the treatment of in-stent restenosis.
    Lee WC; Fang HY; Fang CY
    Coron Artery Dis; 2016 Dec; 27(8):709-710. PubMed ID: 27379437
    [No Abstract]   [Full Text] [Related]  

  • 53. Bioresorbable scaffolds for the treatment of in-stent restenosis.
    Dörr O; Liebetrau C; Wiebe J; Hecker F; Rixe J; Möllmann H; Hamm C; Nef H
    Heart Vessels; 2015 Mar; 30(2):265-9. PubMed ID: 24390727
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treatment options for stent restenosis: insights from intracoronary imaging, clinical trials, and registries.
    Rivero F; Cuesta J; Bastante T; García-Guimaraes M; Alfonso F
    Coron Artery Dis; 2017 Sep; 28(6):507-517. PubMed ID: 28562383
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Excimer Laser Angioplasty-Facilitated Fracturing of Napkin-Ring Peri-Stent Calcium in a Chronically Underexpanded Stent: Documentation by Optical Coherence Tomography.
    Yin D; Maehara A; Mezzafonte S; Moses JW; Mintz GS; Shlofmitz RA
    JACC Cardiovasc Interv; 2015 Jul; 8(8):e137-e139. PubMed ID: 26205458
    [No Abstract]   [Full Text] [Related]  

  • 56. Simple balloon dilation for drug-eluting in-stent restenosis: an optical coherent tomography analysis.
    Arikawa R; Yamaguchi H; Takaoka J; Miyamura A; Atsuchi N; Ninomiya T; Atsuchi Y; Ohishi M; Terashima M; Kaneda H
    Cardiovasc Revasc Med; 2015; 16(1):27-31. PubMed ID: 25578507
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Association of morphologic characteristics on optical coherence tomography and angiographic progression patterns of late restenosis after drug-eluting stent implantation.
    Yamaguchi H; Arikawa R; Takaoka J; Miyamura A; Atsuchi N; Ninomiya T; Atsuchi Y; Ohishi M; Terashima M; Kaneda H
    Cardiovasc Revasc Med; 2015; 16(1):32-5. PubMed ID: 25617940
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of drug-eluting stents after rotational atherectomy: evidence from a multicenter experience.
    Cortese B; Piraino D; Godino C; Aranzulla T; Chizzola G; Ettori F; De Benedictis M; Colombo A
    J Cardiovasc Med (Hagerstown); 2017 May; 18(5):354-358. PubMed ID: 26258723
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The wound healing response after implantation of a drug-eluting stent is impaired persistently in the long term.
    Nasuno T; Tokura M; Kageyama M; Toyoda S; Sakuma M; Komatsu T; Taguchi I; Abe S; Inoue T
    Heart Vessels; 2016 Jun; 31(6):985-9. PubMed ID: 25939630
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Very early in-stent neoatherosclerosis assessed by optical coherence tomography.
    Vergara-Martel A; Pizzato PE; Dallan LAP; Pereira GTR; Richmond HCT; Attizzani GF; Jones MR
    Int J Cardiovasc Imaging; 2019 Oct; 35(10):1793-1794. PubMed ID: 31175526
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.